Baylink Biosciences
Darren B. is a seasoned executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as the Chief Operating Officer at Baylink Biosciences since October 2024, Darren is also a Co-Founder of Tailored Therapeutics, which focuses on personalized cell therapy using T-cells to target tumors while reducing toxicity to healthy tissues. Previous roles include Senior Vice President at Amyris, Senior Vice President of Corporate Development and Strategy at Emergent BioSolutions, and Vice President of Business Development at Clinical Data, Inc. Additionally, Darren has held leadership positions at Ensendar, MiddleBrook Pharmaceuticals, HGS, and PAREXEL, demonstrating a strong background in business development and strategic management across various organizations.
This person is not in the org chart
This person is not in any teams
Baylink Biosciences
Baylink Biosciences is focused on developing innovative antibody-drug conjugates (ADCs) for cancer treatment. Baylink has created a panel of linker-payloads that enhance the delivery of hydrophobic compounds with high drug-to-antibody ratios (DAR) and stability. Baylink is advancing several product candidates based on this platform to the clinic that represent first-in-class or best-in-class ADC therapeutics.